Affordable Access

Publisher Website

Progression-free survival in neuroendocrine tumors: preferred end point, but how should it be defined?

Authors
Type
Published Article
Journal
Journal of Clinical Oncology
1527-7755
Publisher
American Society of Clinical Oncology
Publication Date
Volume
29
Issue
20
Pages
2835–2836
Identifiers
DOI: 10.1200/JCO.2011.36.1030
PMID: 21632510
Source
Medline

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments